The Duke Autism Program has been studying cord blood cells for autism for many years, but their own studies and those clinical trials by others have not found any evidence that cord blood helps autism. Nonetheless the Duke team continues their experiments on children and there are concerns about the source of their funding. I’m also concerned about their possible entanglements with a for-profit stem cell clinic in Panama.
When I first learned about the multi-$10 million cord cell clinic deal between Duke and Cryo-Cell I couldn’t believe what I was reading. Duke’s involved in this? The problem: marketing unproven cells for kids Yes, this wasn’t some stem cell clinic operating out of a strip mall seeking to make big money off of injecting …
Vice tackles dicey Cryo-Cell Duke mega-million peds clinic plan Read More »
I recently found concerning SEC filings from the biotech Cryo-Cell about a deal it has with a Duke team for infusions of children with unproven umbilical cord cells. This turns out to be a $58 million deal. It relates in a major way to a Duke compassionate use or expanded access program (EAP) that already had raised …
FDA should freeze Duke EAP & probe $58 million Cryo-Cell deal linked to it Read More »
The journal Stem Cells Translational Medicine has a long track record of publishing great work. I also have a lot of respect for the editors there and I’ve published there myself. But a few recent events have sparked concerns including over possible undisclosed conflicts of interest in some papers there about cord blood for autism. …
Cord conflicts at the journal Stem Cells Translational Medicine Read More »